Effects of estrogen and estrogen-progesteron on serum nitric oxide metabolite concentrations in post-menopausal women

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Endocrinological Investigation

• Publication date

  2008-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF03346435PMID 19092292
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Menopausal hormone therapy (August 2016)

  2016cited by this paper
• Effects of oestradiol and oestroprogestin on erythrocyte antioxidative enzyme system activity in postmenopausal women

  2006cited by this paper
• The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits – an attempt to interpret the Women's Health Initiative results

  2006cited by this paper
• Selective inhibitors of inducible nitric oxide synthase: potential agents for the treatment of inflammatory diseases?

  2006cited by this paper
• A comparison of effects of sequential transdermal administration versus oral administration of estradiol plus norethisterone acetate on serum NO levels in postmenopausal women.

  2006cited by this paper
• Long-term effect of estrogen replacement on plasma nitric oxide levels: results from the estrogen in the prevention of atherosclerosis trial (EPAT).

  2005cited by this paper
• Effects of transdermal estrogen replacement therapy on plasma levels of nitric oxide and plasma lipids in postmenopausal women.

  2005cited by this paper
• Menopausal hormone therapy.

  2005cited by this paper
• Nitric oxide in postmenopausal women taking three different HRT regimens.

  2005cited by this paper
• Estrogens acting as cardiovascular agents: direct vascular actions.

  2004cited by this paper
• Serum lipid peroxides and total antioxidant status in postmenopausal women on hormone replacement therapy

  2004cited by this paper
• Effects of long-term estrogen replacement therapy versus combined hormone replacement therapy on nitric oxide-dependent vasomotor function.

  2003cited by this paper
• Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

  2002cited by this paper
• Estrogen modulation of endothelial nitric oxide synthase.

  2002cited by this paper
• Lipids and endothelium-dependent vasodilation—A review

  2002cited by this paper
• A comparison of the effects of two continuous HRT regimens on cardiovascular risk factors.

  2002cited by this paper
• Effects of estrogen in the regulation of nitric oxide pathway during development of hypertension in rats.

  2002cited by this paper
• Postmenopausal hormone replacement therapy: scientific review.

  2002cited by this paper
• Novel non-transcriptional mechanisms for estrogen receptor signaling in the cardiovascular system. Interaction of estrogen receptor alpha with phosphatidylinositol 3-OH kinase.

  2002cited by this paper
• Vascular effects of hormones.

  2001cited by this paper
• Effects of the menopause, gender, and estrogen replacement therapy on vascular nitric oxide activity.

  2000cited by this paper
• [Influence of the presence of hot flashes during menopause on the metabolism of nitric oxide. Effects of hormonal replacement treatment].

  2000cited by this paper
• Znaczenie upośledzenia śródbłonkowej produkcji tlenku azotu w patogenezie chorób układu krążenia, część

  2000cited by this paper
• Influencia de la presencia de sofocos durante la menopausia sobre el metabolismo del óxido nítrico. Efecto del tratamiento hormonal sustitutivo

  2000cited by this paper
• Inhibition of copper/zinc superoxide dismutase impairs NO.-mediated endothelium-dependent relaxations.

  1999cited by this paper
• Inhibition of copper/zinc superoxide dismutase impairs NO ⋅-mediated endothelium-dependent relaxations.

  1999cited by this paper
• Relationships between nitric oxide, nitroxyl ion, nitrosonium cation and peroxynitrite.

  1999cited by this paper
• Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

  1998cited by this paper
• The long-term effects of oral and transdermal postmenopausal hormone replacement therapy on nitric oxide, endothelin-1, prostacyclin, and thromboxane.

  1998cited by this paper
• Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate.

  1997cited by this paper
• The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women.

  1997cited by this paper
• Circulating levels of nitric oxide in fertile women in relation to the menstrual cycle.

  1996cited by this paper
• Up‐regulation of nitric oxide synthase by estradiol in human aorticendothelial cells

  1995cited by this paper
• The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease.

  1995cited by this paper
• Oxidized Low-density Lipoprotein Decreases the Expression of Endothelial Nitric Oxide Synthase (*)

  1995cited by this paper
• Induction by estrogens of lipid peroxidation and lipid peroxide-derived malonaldehyde-DNA adducts in male Syrian hamsters: role of lipid peroxidation in estrogen-induced kidney carcinogenesis.

  1995cited by this paper
• Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol and norethisterone acetate. A two-year follow-up study.

  1995cited by this paper
• Prostacyclin and nitric oxide.

  1994cited by this paper
• Induction of calcium-dependent nitric oxide synthases by sex hormones.

  1994cited by this paper
• Cellular mechanisms of atherogenesis and the effects of nitric oxide

  1992cited by this paper
• Nitric oxide: physiology, pathophysiology, and pharmacology.

  1991cited by this paper
• Estrogens as natural antioxidants of membrane phospholipid peroxidation

  1987cited by this paper
• Inhibitory effect of female hormones on lipid peroxidation.

  1986cited by this paper
• Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure.

  1982cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper

• Skin temperature and nitric oxide in premenopausal and postmenopausal women with fibromyalgia

  2025cites this paper
• Physalis minima leaf extract improves endothelium-dependent vasodilation and decreases blood pressure in ovariectomized rats

  2024cites this paper
• Understanding human aging and the fundamental cell signaling link in age-related diseases: the middle-aging hypovascularity hypoxia hypothesis

  2023cites this paper
• Reduced Dehydroepiandrosterone-Sulfate Levels in the Mid-Luteal Subphase of the Menstrual Cycle: Implications to Women’s Health Research

  2022cites this paper
• Long-term inorganic nitrate administration protects against ovariectomy-induced osteoporosis in rats

  2022cites this paper
• Sex-Based Evaluation of Lipid Profile in Postoperative Adjuvant Mitotane Treatment for Adrenocortical Carcinoma

  2022cites this paper
• Forearm vasodilatation to a β2‐adrenergic receptor agonist in premenopausal and postmenopausal women

  2020cites this paper
• Circulating markers of nitric oxide homeostasis and cardiometabolic diseases: insights from population-based studies

  2019cites this paper
• Differential menopause- versus aging-induced changes in oxidative stress and circadian rhythm gene markers.

  2017cites this paper
• Increasing dietary nitrate has no effect on cancellous bone loss or fecal microbiome in ovariectomized rats

  2017cites this paper
• The protective role of oestradiol against silent myocardial ischemia and hypertension risk in South African men: The SABPA study.

  2017cites this paper
• Women-Specific Factors to Consider in Risk, Diagnosis and Treatment of Cardiovascular Disease

  2015cites this paper
• Einfluss von Flickerlicht auf den retinalen Gefäßdurchmesser unter Berücksichtigung des weiblichen Hormonzyklus innerhalb eines Monats

  2015cites this paper
• The Menopause and Oxidative Stress

  2013cites this paper
• Chapter 11 The Menopause and Oxidative Stress

  2012cites this paper
• Topical nitrates for osteoporosis: a cheap future direction?

  2011cites this paper
• Progesterone antagonizes estrogen in FMD 1 1 2 Short-term oral progesterone administration antagonizes the effect of transdermal 3 estradiol on endothelium-dependent vasodilation in young healthy women 4 5 6 7

  2011cites this paper
• Short-term oral progesterone administration antagonizes the effect of transdermal estradiol on endothelium-dependent vasodilation in young healthy women.

  2011cites this paper
• Ethinylestradiol and estradiol have different effects on oxidative stress and nitric oxide synthesis in human endothelial cell cultures.

  2010cites this paper
• Sex differences in the coronary vasodilation induced by 17 β‐oestradiol in the isolated perfused heart from spontaneously hypertensive rats

  2010cites this paper
• Potentiation of vascular oxidative stress and nitric oxide-mediated endothelial dysfunction by high-fat diet in a mouse model of estrogen deficiency and hyperandrogenemia.

  2009cites this paper